Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Tianshun Pharmaceutical is a comprehensive pharmaceutical enterprise based in China that focuses on the research, development, production, and sale of chemical drugs and traditional Chinese medicines. The company operates large-scale manufacturing facilities that produce a wide range of dosage forms, including tablets, capsules, granules, and small-volume injections. Its product portfolio covers several therapeutic areas such as cardiovascular health, digestive system treatments, and anti-infectives. Shandong Tianshun Pharmaceutical is recognized for its adherence to Good Manufacturing Practice (GMP) standards and its commitment to providing affordable healthcare solutions to the domestic Chinese market. The company also engages in the production of active pharmaceutical ingredients (APIs) to support its finished dosage form business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Tianshun Pharmaceutical.